Brokers’ take: CGS-CIMB upgrades Raffles Medical to ‘add’ with higher S$1.22 target price

CGS-CIMB on Friday upgraded Raffles Medical Group to “add” from “hold”, citing its position as a key private player supporting Covid-19 testing, especially as the dominant tester for Changi Airport.
Read More